The March 18, 2010 issue of *New England Journal of Medicine* (Volume 362, #11, March 18) includes a study: "Clinical Trials That Explicitly Exclude Gay and Lesbian Patients." The authors are Brian L. Egleston, Ph.D., Roland L. Dunbrack, Jr., Ph.D., & Michael J. Hall, M.D. Here's how the report starts: "We recently encountered proposed studies [...]
I just saw that Dana Jennings, who writes a blog about his prostate cancer for the NYT, is discussing language and cancer. So I recycled this essay I wrote some time back. It amazes me that doctors still use the word biochemical failure to refer to a recurrence of prostate cancer. A doctor told me, [...]
I have been reading in the press about a recent medical malpractice settlement surrounding prostate cancer. Briefly, a man went to his primary care physician who, along with other tests, performed a DRE and PSA test. The doctor failed to inform his patient about the negative test results which were indicative of a diagnosis of [...]
A story about prostate cancer (PC) screening titled "The Great Prostate Mistake" which appeared in the New York Times last week, "went viral". Everybody's talking about it. (See http://www.nytimes.com/2010/03/10/opinion/10Ablin.html?scp=1&sq=ablin&st=cse) I refer to an opinion piece written by Dr. Richard Ablin, a researcher in immunobiology and pathology who invented the prostate-specific antigen (PSA) test in 1970, the most commonly used [...]
Roche Pharmaceuticals has reported that their clinical trial of Avastin in men with advanced prostate cancer did not improve their overall life expectancy. […]